Ignite Creation Date:
2025-12-24 @ 11:37 PM
Ignite Modification Date:
2026-05-29 @ 8:37 AM
Study NCT ID:
NCT04624256
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-05-13
First Post:
2020-10-26
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Germline DNA-Based Radiosensitivity Biomarker Influence on Toxicity Following Prostate Radiotherapy, GARUDA Trial
Sponsor:
Jonsson Comprehensive Cancer Center
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Prostate Adenocarcinoma | View |
| None | Stage I Prostate Cancer American Joint Committee on Cancer (AJCC) … | View |
| None | Stage II Prostate Cancer AJCC v8 | View |
| None | Stage IIA Prostate Cancer AJCC v8 | View |
| None | Stage IIB Prostate Cancer AJCC v8 | View |
| None | Stage IIC Prostate Cancer AJCC v8 | View |
Keywords: